openPR Logo
Press release

COVID-19 is Impact on Nanomedicine Market Target to Reach $261,063 million by 2023, at CAGR of 12.6% | Abbott Laboratories, CombiMatrix Corporation, General Electric Company

06-22-2020 11:08 AM CET | Health & Medicine

Press release from: Allied Market Research

Nanomedicine Market

Nanomedicine Market

UPDATE AVAILABLE ON-DEMAND

According to a new report published by Allied Market Research, titled, "Nanomedicine Market by Modality (Treatments and Diagnostics), Application (Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, and Others), and Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Diseases, Urological Diseases, Ophthalmological Diseases, Immunological Diseases, and Others) - Global Opportunity Analysis and Industry Forecast, 2019-2026" The report has offered an all-inclusive analysis of the global Nanomedicine Market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment pockets, future prospects, and trends. At the start, the report lays emphasis on the key trends and opportunities that may emerge in the near future and positively impact the overall industry growth.

The global nanomedicine market was valued at $111,912 million in 2016, and is projected to reach $261,063 million by 2023, growing at a CAGR of 12.6% from 2017 to 2023. The drug delivery segment accounted for nearly two-fifths share of the global market in 2016.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/2021

Key drivers that are propelling the growth of the market included in the report. Additionally, challenges and restraining factors that are likely to curb the growth of the market are put forth by the analysts to prepare the manufacturers for future challenges in advance.

The report presents in-depth insights into each of Modality, and Indication. verticals along with annual forecasts to 2027. The report provides revenue forecast with sales, and sales growth rate of the global Nanomedicine market. The forecasts are also provided with respect to the Modality, and Indication segments of the market. The forecasts are issued to understand the future outlook and prospects of the industry.

The market is evaluated based on its regional penetration, explaining the performance of the market in each regional market covering provinces such as North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2021

Top 10 leading companies in the global Nanomedicine market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile and Nanomedicine products and services. The key players operating in the global Nanomedicine industry include Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., and Teva Pharmaceutical Industries Ltd.

The other prominent players in the value chain include Celgene Corporation, UCB (Union Chimique Belge) S.A., AMAG Pharmaceuticals, Nanospectra Biosciences, Inc., Arrowhead Pharmaceuticals, Inc., Leadiant Biosciences, Inc., Epeius Biotechnologies Corporation, Gilead, and Cytimmune Sciences, Inc.

Latest news and industry developments in terms of market expansions, acquisitions, growth strategies, joint ventures and collaborations, product launches, market expansions etc. are included in the report.

Key Benefits:

• The report provides a qualitative and quantitative analysis of the current Nanomedicine market trends, forecasts, and market size from 2020 to 2027 to determine the prevailing opportunities.
• Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.
• Top impacting factors & major investment pockets are highlighted in the research.
• The major countries in each region are analyzed and their revenue contribution is mentioned.
• The market report also provides an understanding of the current position of the market players active in the Nanomedicine industry.

Highlights of the Report:

• Competitive landscape of the Nanomedicine Market.
• Revenue generated by each segment of the Nanomedicine market by 2027.
• Factors expected to drive and create new opportunities in the Nanomedicine industry.
• Strategies to gain sustainable growth of the market.
• Region that would create lucrative business opportunities during the forecast period.
• Top impacting factors of the Nanomedicine market.

Access Full Report Summary: https://www.alliedmarketresearch.com/nanomedicine-market

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19 is Impact on Nanomedicine Market Target to Reach $261,063 million by 2023, at CAGR of 12.6% | Abbott Laboratories, CombiMatrix Corporation, General Electric Company here

News-ID: 2078312 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Nanomedicine

Nanomedicine Market Will Generate Huge Revenue in Future 2030 | Abbott Laborator …
Coherent Market Insights recently released a research report titled "Nanomedicines Market Insight, Forecast to 2030", which assesses various factors influencing its trajectory. The report extensively discusses the market, offering readers a comprehensive understanding of key trends, top strategies, and potential growth opportunities. Porter's Five Forces analysis, PESTEL analysis, as well as qualitative and quantitative analysis are used to present a complete and precise picture of the current and future market
Nanomedicine Market Analytical Overview and Growth
Nanomedicine Market: Overview • According to Transparency Market Research's latest report on the global nanomedicine market for the historical period 2017-2019 and forecast period from 2021 to 2028, increase in research funding, rise in government support, improved regulatory framework, technological advancements, and surge in prevalence of chronic diseases are projected to drive the global nanomedicine market during the forecast period Read Report Overview- https://www.transparencymarketresearch.com/nanomedicine-market.html Rise in Prevalence of Chronic Diseases such as Cancer and
Cancer Nanomedicine Market Cancer Nanomedicine Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Cancer Nanomedicine: An Optimistic Avenue 1.1 Introduction 1.2 Emergence of Nanomedicines Prerequisite of Nanomedicines 2.1 Conventional Cancer Treating Approaches 2.2 Nanomedicines: Overcoming the Hurdles Diversification of Nanomedicines 3.1 Classification on Basis of Constituents 3.1.1 Inorganic Nanoparticles 3.1.2 Organic Nanoparticles 3.2 Classification on Basis of Applicability 3.2.1
Global Cancer Nanomedicine Market & Cancer Nanomedicine Clinical Trials Outlook …
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, very recent breakthroughs in nanomedicine have
Global Nanomedicine Market & Pipeline Insight 2015
Nanomedicines or nanotherapeutics is an emerging field in which nanotechnology principles are used to design and develop better therapeutics having high safety and efficacy profiles. It is a multidisciplinary approach utilizing knowledge from allied fields like biotechnology and pharmacology in drug development program. Novel modalities for cancer treatment, targeted drug delivery, biosensors, imaging, delivery vehicles and diagnostic methods are being actively investigated by pharmaceutical companies. They have been widely accepted
Global Cancer Nanomedicine Market Outlook 2022
Over the past several years, many innovative and revolutionary techniques have been developed in order to treat cancer. These techniques range from basic surgical removal to X-ray irradiation to system wide flooding with anticancer agents. However, each of these approaches has its own series of undesirable side effects that are both dangerous and damaging to the overall health of the patient. On the contrary, recent breakthroughs in nanomedicine have managed